Key regions: China, South Korea, Canada, India, France
The Analgesics (Pharmacies) market in G7 is experiencing significant growth and development due to various factors. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to the current state of the market.
Customer preferences: Customers in the G7 countries have shown a strong preference for analgesics purchased from pharmacies. This preference can be attributed to several factors, including the trust and reliability associated with pharmacies, the convenience of purchasing medication alongside other healthcare products, and the availability of professional advice from pharmacists. Additionally, customers in these countries tend to prioritize quality and safety when purchasing analgesics, and pharmacies are often perceived as more trustworthy sources compared to other retail channels.
Trends in the market: One notable trend in the Analgesics (Pharmacies) market in G7 is the increasing demand for over-the-counter (OTC) analgesics. This trend can be attributed to several factors, including the growing awareness and acceptance of self-medication practices, the rising prevalence of chronic pain conditions, and the availability of a wide range of OTC analgesics that cater to different needs and preferences. Furthermore, the aging population in G7 countries has also contributed to the increased demand for analgesics, as older individuals are more likely to experience pain and seek relief through medication.
Local special circumstances: Each G7 country has its own unique set of circumstances that influence the development of the Analgesics (Pharmacies) market. For example, in the United States, the high healthcare costs and the prevalence of health insurance coverage have a significant impact on the market dynamics. In Japan, the aging population and the cultural emphasis on self-care contribute to the demand for analgesics. In Germany, the strong pharmaceutical industry and the focus on quality and efficacy shape the market landscape. These local special circumstances play a crucial role in shaping customer preferences and market trends.
Underlying macroeconomic factors: Several underlying macroeconomic factors contribute to the development of the Analgesics (Pharmacies) market in G7. Economic stability, income levels, and healthcare expenditure are significant factors that influence the affordability and accessibility of analgesics. Additionally, government regulations and policies related to healthcare, pharmaceuticals, and retail also impact the market dynamics. For example, price regulations, reimbursement policies, and advertising restrictions can all affect the availability and pricing of analgesics in pharmacies. In conclusion, the Analgesics (Pharmacies) market in G7 is developing and growing due to customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. The strong preference for pharmacy purchases, the increasing demand for OTC analgesics, and the unique circumstances of each G7 country all contribute to the current state of the market. Additionally, factors such as economic stability, income levels, and government regulations also play a significant role in shaping the market dynamics.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
